Biography

Gregg C. Fonarow, MD, FACC, FAHA, FHFSA is the Eliot Corday Professor of Cardiovascular Medicine and Science at UCLA. He serves as Chief of the UCLA Division of Cardiology (Interim), Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-Director of UCLA’s Preventative Cardiology Program. He attained the rank of Professor of Medicine, Geffen School of Medicine at UCLA in 2003. His research interests center on acute and chronic heart failure, preventative cardiology, quality of care, outcomes, and implementing treatment systems to improve clinical outcomes. Dr. Fonarow has published over 1400 research studies and clinical trials in heart failure, disease management, preventative cardiology, and outcomes research. Each year 2014 to 2022, Dr. Fonarow has been selected by Clarivate for the list of Highly Cited Researchers, which identifies the world’s most influential contemporary researchers across 21 scientific fields with the greatest number of published articles that received marks for exceptional impact. In 2015, Dr. Fonarow received a Clinical Research Forum Distinguished Clinical Achievement Award. In 2017, Dr. Fonarow received the AHA National Chairman’s Award. In 2019, he received the Outstanding Lifetime Achievement Award from the AHA Quality of Care and Outcomes Research Council. In 2020, Dr. Fonarow became a Member of the Association of University Cardiologists. This organization was founded in 1961 and is only limited to an active membership of 135 academic cardiologists (who shape the course of research and training in cardiovascular disease) from the United States, elected by their peers. In 2022, Dr. Fonarow was the recipient of the American Heart Association’s Gold Heart Award.

Read More